60 DEGREES PHARMACEUTICALS INC C/WTS 12/07/2028 (TO PUR COM)(SXTPW.US)

Dow Jumps 300 Points; Procter & Gamble Shares Gain After Q2 Results

U.S. stocks rose, with the Dow Jones up 300 points to 49,387.01. Procter & Gamble shares gained 2% after reporting Q2 adjusted EPS of $1.88, beating estimates, but sales missed expectations. Notable stock movements included 60 Degrees Pharmaceuticals surging 297% and C3is Inc. dropping 37% after a reverse stock split. Commodities saw oil down 1.9% and gold up 0.2%. European and Asian markets also closed higher. U.S. initial jobless claims rose to 200,000, while the economy grew at an annualized rate of 4.4% in Q3.

Wall Street Set to Open Higher Thursday as Investors Parse GDP, Unemployment Data, Look Ahead to Inflation Report

US stocks are set to open higher as investors analyze GDP and unemployment data, with Dow futures up 0.5%, S&P 500 futures up 0.7%, and Nasdaq futures up 1%. Q3 GDP growth was reported at 4.4%, while jobless claims rose to 200,000. Oil prices fell by 1.2%. Notable stock movements include iOThree up 123% and 60 Degrees Pharmaceuticals up 191%. Conversely, Galaxy Payroll Group shares dropped 20%. Core inflation data and oil inventory figures are expected later today.

Here's Why 60 Degrees Pharmaceuticals Stock (SXTP) Rocketed Today

60 Degrees Pharmaceuticals (SXTP) stock surged 168% in pre-market trading after announcing a partnership with Runway Health to enhance access to ARAKODA for malaria prevention among travelers. The collaboration will utilize Runway Health's telehealth platform starting April 2, 2026. Despite this rally, SXTP stock has seen a year-to-date decline of 1.62% and an 88.62% drop over the past year, with over 92 million shares traded today compared to a three-month average of 200,000.

60 Degrees Pharmaceuticals shares are trading higher after the company announced a partnership with Runway Health to expand pre-departure access to ARAKODA.

60 Degrees Pharmaceuticals Partners with Runway Health to Expand Access to Malaria Prevention

60 Degrees Pharmaceuticals Inc. has partnered with Runway Health to enhance access to its malaria prevention medication, ARAKODA® (tafenoquine), for international travelers. This collaboration allows travelers to utilize the Runway Health telehealth platform for physician-led consultations and obtain ARAKODA® before traveling to malaria-endemic areas, aiming to provide personalized treatment plans and greater convenience for malaria prevention.